Sequential Chemotherapy and Lenalidomide Followed by Rituximab and Lenalidomide Maintenance for Untreated Mantle Cell Lymphoma: A Phase II Study
Phase of Trial: Phase II
Latest Information Update: 11 Apr 2017
At a glance
- Drugs Lenalidomide (Primary) ; Rituximab (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Vincristine
- Indications Mantle-cell lymphoma
- Focus Therapeutic Use
- 06 Apr 2017 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 06 Apr 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
- 23 Dec 2015 New trial record